Deals of the Week: Options Abound As Forest Keeps Its Eyes On A Prize-Winner
Executive Summary
Reflecting a long trend, three of this past week’s deals include option arrangements, including one with a new twist. Also, a rare disease partnership between Shire and Atlas Venture finally leads to a deal and Takeda continues building its vaccines business.